|Bid||138.98 x 50000|
|Ask||140.35 x 50000|
|Day's Range||138.37 - 138.37|
|52 Week Range||115.04 - 172.00|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CVS Health tapped a former Eli Lilly finance chief to run its pharmacy benefit business as the drugstore giant works to complete an acquisition of insurer Aetna.
After being the only one to finish 2016 in the red, the healthcare sector made a comeback in 2017 and finished the year up 21.7%, barely lagging the S&P 500’s (SPX) 21.83% increase. It’s still early in ...
Aetna shareholders voted overwhelmingly Tuesday to approve the CVS Health's plan to buy the health insurer for $69 billion. Once the deal is completed, Aetna (AET) shareholders will receive $145 in cash and 0.8378 of a CVS Health (CVS) share for each Aetna share they own. CVS shareholders also voted in favor of the deal at a special meeting Tuesday.
CVS Health Corp. and Aetna Inc. stockholders have voted to approve the pharmacy company’s acquisition of the health insurer.
At today’s special meeting of Aetna shareholders, approximately 97 percent of the votes cast, and over 77 percent of the 326,942,525 shares outstanding and entitled to vote, voted to approve and adopt the agreement and plan of merger dated as of December 3, 2017, as it may be amended from time to time, pursuant to which CVS Health has agreed to acquire Aetna.
WOONSOCKET, R.I., March 13, 2018 /PRNewswire/ -- In a special meeting held today, CVS Health Corporation (CVS) stockholders voted to approve the shares of company stock to be issued in the company's acquisition of Aetna Inc. (AET), one of the nation's leading diversified health care benefits companies. "When this merger is complete, the combined company will be well-positioned to reshape the consumer health care experience, putting people at the center of health care delivery to ensure they have access to high-quality, more affordable care where they are, when they need it," said Larry Merlo, CVS Health president and CEO.
Drug retail chain CVS has completed a $40 billion bond sale, the third-largest corporate bond sale on record, to finance its proposed acquisition of health insurer Aetna.
Humana, Aetna and other providers enhance revenue by shuffling customers among privately managed plans. The tactic, known as crosswalking, adds millions of dollars in federal payments to the companies ...
Humana Inc, Aetna Inc and other insurance providers enhance revenue by shuffling customers among privately managed plans, the Wall Street Journal reported on Sunday. Source link: https://www.wsj.com/articles/insurers-game-medicare-system-to-boost-federal-bonus-payments-1520788658?mod=searchresults&page=1&pos=1 ...
In the not-too-distant future, your health insurance, your prescription drugs and some of your treatment may come from the same company.
Cigna’s $54 billion deal for Express Scripts is the latest sign that health care’s biggest players believe they can no longer go it alone, and they must branch into other businesses to forge integrated ...
CVS Health Corp.’s outstanding bonds fell Tuesday, as the company geared up for an offering of $40 billion of new debt to be used to finance the company’s proposed acquisition of Aetna Corp.
Pharmacy chain CVS Health Corp. sold $40 billion of bonds Tuesday to help pay for its acquisition of health insurer Aetna Inc. months before it needs the money, seeking to get ahead of an expected rise in interest rates and a flood of borrowing across the economy. The sale, the largest in two years, showed there is still eager demand from investors for corporate bonds issued by financially strong borrowers. Investors are anticipating a deluge of bond issuance this year.
It will likely be a while before CVS Health Corp. completes its $68 billion purchase of insurer Aetna Inc. But it's already laying the very expensive groundwork.
Moody's Investors Service, ("Moody's") today assigned a Baa1 rating to CVS Health's (CVS) new proposed $40 billion senior unsecured notes offering. The rating remains on review for downgrade. ...
CVS Health Corp. completed the third-largest corporate bond sale on record to fund its acquisition of Aetna Inc., testing the appetite of a market that’s off to its worst annual start in decades.
Moody's Investors Service, ("Moody's") affirmed the ratings of CVS Credit Lease Backed Pass-Through Certificates, Series A-1 and Series A-2: Series A-2, Affirmed Ba1; previously on Mar 23, 2017 ...
Moody's Investors Service, ("Moody's") placed the ratings of 12 credit tenant lease (CTL) transactions supported by CVS Health (CVS) lease obligations on review for possible downgrades. Issuer: ...
Express Scripts Holding Co would take a look at any Medicare pharmacy drug plans up that go up for sale including those of Aetna Inc or CVS Health Corp as its rivals seek antitrust approvals on their $69 billion deal, Express Chief Executive Officer Tim Wentworth said on Wednesday. Wentworth, the morning after the company reported higher fourth-quarter profit, was speaking to Wall Street analysts about its interest in expanding managing the pharmacy benefits provided under the Medicare program for older or disabled people. "If a meaningful book of business is coming to the market, we would take a look," Wentworth said.
Aetna Inc (NYSE:AET) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Aetna Inc is a diversified health care benefits company.